Correction: Right atrial volume by cardiovascular magnetic resonance predicts mortality in patients with heart failure with reduced ejection fraction.

$Right atrial volume by cardiovascular magnetic resonance predicts mortality in patients with heart failure with reduced ejection fraction.$
Right atrial volume by cardiovascular magnetic resonance predicts mortality in patients with heart failure with reduced ejection fraction.

Atrioventricular Conduction Delay Predicts Impaired Exercise Capacity in Patients with Heart Failure with Reduced Ejection Fraction.

$Chronic heart failure with reduced ejection fraction.$
Chronic heart failure with reduced ejection fraction.

$Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction.$
Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction.

$Statins beneficial for heart failure with preserved ejection fraction but not heart failure with reduced ejection fraction?$
Statins beneficial for heart failure with preserved ejection fraction but not heart failure with reduced ejection fraction?

$Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.$
Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.

$Benefits of chronic total coronary occlusion percutaneous intervention in patients with heart failure and reduced ejection fraction: insights from a cardiovascular magnetic resonance study.$
Benefits of chronic total coronary occlusion percutaneous intervention in patients with heart failure and reduced ejection fraction: insights from a cardiovascular magnetic resonance study.

$Outcomes in patients with heart failure with preserved ejection fraction.$
Outcomes in patients with heart failure with preserved ejection fraction.

Pharmacotherapy Choice Is Associated with 2-Year Mortality for Patients with Heart Failure and Reduced Ejection Fraction.

$Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.$
Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.

$C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction.$
C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction.

Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes.

$Racial differences in mortality in patients with advanced systolic heart failure: potential role of right ventricular ejection fraction.$
Racial differences in mortality in patients with advanced systolic heart failure: potential role of right ventricular ejection fraction.

$Exhausted atrial reserve by tissue Doppler echocardiography: a risk marker in heart failure with reduced ejection fraction.$
Exhausted atrial reserve by tissue Doppler echocardiography: a risk marker in heart failure with reduced ejection fraction.

$Ventricular arrhythmias in patients with heart failure secondary to reduced ejection fraction: a current perspective.$
Ventricular arrhythmias in patients with heart failure secondary to reduced ejection fraction: a current perspective.

$Hemodynamic responses to small muscle mass exercise in heart failure patients with reduced ejection fraction.$
Hemodynamic responses to small muscle mass exercise in heart failure patients with reduced ejection fraction.

$Prognosis of patients with heart failure and reduced ejection fraction in China.$
Prognosis of patients with heart failure and reduced ejection fraction in China.

$Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction.$
Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction.

$[Heart failure with preserved ejection fraction (HFpEF)].$
[Heart failure with preserved ejection fraction (HFpEF)].

$Heart failure with preserved ejection fraction.$
Heart failure with preserved ejection fraction.

$Determinants of exercise intolerance in patients with heart failure and reduced or preserved ejection fraction.$
Determinants of exercise intolerance in patients with heart failure and reduced or preserved ejection fraction.

$valsartan versus enalapril in patients with heart failure and reduced ejection fraction.$
valsartan versus enalapril in patients with heart failure and reduced ejection fraction.



Suggest Documents

Right atrial volume by cardiovascular magnetic resonance predicts mortality in patients with heart failure with reduced ejection fraction.

Atrioventricular Conduction Delay Predicts Impaired Exercise Capacity in Patients with Heart Failure with Reduced Ejection Fraction.

Chronic heart failure with reduced ejection fraction.

Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction.

Statins beneficial for heart failure with preserved ejection fraction but not heart failure with reduced ejection fraction?

Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.

Benefits of chronic total coronary occlusion percutaneous intervention in patients with heart failure and reduced ejection fraction: insights from a cardiovascular magnetic resonance study.

Outcomes in patients with heart failure with preserved ejection fraction.

Pharmacotherapy Choice Is Associated with 2-Year Mortality for Patients with Heart Failure and Reduced Ejection Fraction.

Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.

C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction.

Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes.

Racial differences in mortality in patients with advanced systolic heart failure: potential role of right ventricular ejection fraction.

Exhausted atrial reserve by tissue Doppler echocardiography: a risk marker in heart failure with reduced ejection fraction.

Ventricular arrhythmias in patients with heart failure secondary to reduced ejection fraction: a current perspective.

Hemodynamic responses to small muscle mass exercise in heart failure patients with reduced ejection fraction.

Prognosis of patients with heart failure and reduced ejection fraction in China.

Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction.

[Heart failure with preserved ejection fraction (HFpEF)].

Heart failure with preserved ejection fraction.

Determinants of exercise intolerance in patients with heart failure and reduced or preserved ejection fraction.

valsartan versus enalapril in patients with heart failure and reduced ejection fraction.

Heart failure with preserved ejection fraction.

Heart failure with preserved ejection fraction.

Correction: Right atrial volume by cardiovascular magnetic resonance predicts mortality in patients with heart failure with reduced ejection fraction.

Recommend Documents

Follow Us